MEDIAN Technologies And South Texas Accelerated Research Therapeutics Sign Collaborative Agreement

SOPHIA ANTIPOLIS, France & SAN ANTONIO--(BUSINESS WIRE)--Regulatory News: MEDIAN Technologies (Paris:ALMDT), a leading medical imaging software solutions developer and a service provider for image interpretation and management in oncology clinical trials and clinical routine, today announced it has signed a three-year collaborative agreement with South Texas Accelerated Research Therapeutics (START). With centers located in San Antonio, Texas, and Madrid, Spain, START conducts the world’s largest Phase I medical oncology program, putting more than 400 patients per year in Phase I trials. The mission of START is to accelerate the development of new anticancer drugs that will improve the quality of life and survival for patients.

Help employers find you! Check out all the jobs and post your resume.